Tanimoto Sarina sold SPRY
March 15, 2024 · Form 4 insider transaction
Tanimoto Sarina sold 48,295 shares of ARS Pharmaceuticals, Inc. at $9.14 per share, a transaction worth $441.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.; The weighted average sale price for the transaction reported was $9.1415, and the range of prices were between $9.01 and $9.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided; The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.